Skip to content
HowShorted

MicroVision, Inc. short interest in 2024

In 2024, MicroVision, Inc.'s disclosed short interest ran from 26.67% of shares outstanding on 12 Jan 2024 to 26.14% on 31 Dec 2024, a change of -0.53 percentage points. The year's high was 27.66% on 31 Jul 2024 and its low 21.44% on 15 Nov 2024, averaging 25.35% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 53.61 days on 30 Aug 2024. Full history: MicroVision, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for MicroVision, Inc. in 2024

2024 in figures

Start of year
26.67% (12 Jan 2024)
End of year
26.14% (31 Dec 2024)
Change
-0.53 pp
High
27.66% (31 Jul 2024)
Low
21.44% (15 Nov 2024)
Average
25.35%
Highest days to cover
53.61 (30 Aug 2024)
SEC filings marked
9

Every report in 2024

MicroVision, Inc. short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 202426.67%27.80
31 Jan 202426.32%27.63
15 Feb 202425.42%29.87
29 Feb 202424.72%22.03results (8-K), 10-K filed
15 Mar 202424.34%13.45
28 Mar 202424.44%16.42
15 Apr 202426.51%27.23
30 Apr 202426.70%37.83
15 May 202426.33%15.46results (8-K), 10-Q filed
31 May 202427.01%18.41
14 Jun 202427.45%21.23
28 Jun 202427.04%15.74
15 Jul 202426.96%30.83
31 Jul 202427.66%24.93
15 Aug 202425.81%21.51results (8-K), 10-Q filed
30 Aug 202426.20%53.61
13 Sep 202426.30%33.92
30 Sep 202424.80%33.11
15 Oct 202423.02%34.10results (8-K)
31 Oct 202422.58%24.36
15 Nov 202421.44%18.2910-Q filed, results (8-K)
29 Nov 202421.70%21.22
13 Dec 202422.76%14.18
31 Dec 202426.14%4.89

See also: MicroVision, Inc.'s full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.